Navigation Links
Expanding cell girth indicates seriousness of breast cancer
Date:9/18/2008

WEST LAFAYETTE, Ind. - How fat cells become after being exposed to a specialized electrical field is helping researchers determine whether cells are normal, cancerous or a stage of cancer already invading other parts of the body.

Purdue University scientists tested the electrical process and found cells that expanded the most were metastatic cancer, the term used when the disease has spread beyond its point of origin. The technique allows screening of single cells 300 times faster - five cells per second compared with the one cell per minute of previous methods, said Chang Lu, senior and corresponding author of the study currently online in the journal Analytic Chemistry. This rapid cell inspection permits testing of enough cells for diagnosis and determination of the disease's level, he said.

"If you look at the properties of only a few cells, it would be a stretch to say they exactly represent a tissue cell population since tissues have tens of thousands of cells," Lu said. "Our goal is to have a tool so that we can reputably look at large numbers of cells and obtain information about their biomechanical properties."

Using breast cancer cells, Lu and his research team investigated cancer cells at different stages and compared their size to normal cells after all three types of cells were treated with the electrical process.

The research technique uses an electrical field within a microscopic fluid-filled channel through which a cell moves. As the cell is exposed to the electricity, it swells.

The cell expansion results because as cancer develops, it compromises the cell's structure, or cytoskeleton. A metastatic cancer cell cytoskeleton is more prone to deformity than a primary cancer cell or a normal cell, said Lu, an assistant professor of agricultural and biological engineering. When cells were put through the electrical field that Lu and his colleagues used, pores opened in the cell membrane, allowing fluid from the microchannel into the cell itself.

Just like a person gaining a lot of weight, the cells balloon in size, with the biggest deformity appearing in the metastatic cells.

"Our approach - microfluidic electroporative flow cytometry - can exactly characterize the degree to which a cell can become deformed," Lu said.

A patent is pending on the technique.

The amount of electricity and the length of time the cell is exposed to it also determined how much the various types of cells expanded. Under the parameters that Lu's team used, the metastatic cells expanded by 75 percent after electroporation, while primary cancer cells and normal cells expanded by 50 percent and 25 percent, respectively.

The Purdue scientists used a camera to measure how many cells were being screened over a predetermined time period. The camera must be able to capture changes in each cell one frame at a time.

The scientists want to make the screening process even faster, so they need a camera that can shoot frames even more rapidly than the one Lu's team used for this study. This would provide more accurate measurement of cell expansion. They also want to use the technique to diagnose other types of cancers and other diseases. Tests on a blood disease already are under way.

The eventual goal is to apply microfluidic electroporative flow cytometry in patient trials, Lu said.

"But things become more complicated if you're dealing with patient tissues rather than cell lines," he said. "Cell lines contain only one type of cell; patient tissues have different kinds of cells."


'/>"/>

Contact: Susan Steeves
ssteeves@purdue.edu
765-496-7481
Purdue University
Source:Eurekalert  

Related biology news :

1. European Union forests expanding, absorbing carbon at surprisingly high rate: study
2. Birds migrate together at night in dispersed flocks, new study indicates
3. Flowers fragrance diminished by air pollution, University of Virginia study indicates
4. New molecular clock from LLNL and CDC indicates smallpox evolved earlier than believed
5. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
6. Stem cells may solve mystery of early pregnancy breast cancer protection
7. Vaccine against HER2-positive breast cancer offers complete protection in lab
8. 31st Annual San Antonio Breast Cancer Symposium
9. Growth factor predicts poor outcome in breast cancer
10. CSHL scientists identify new drug target against virulent type of breast cancer
11. Codeine not safe for all breastfeeding moms and their babies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Expanding cell girth indicates seriousness of breast cancer
(Date:3/22/2017)... , March 21, 2017 Vigilant ... company serving law enforcement agencies, announced today the appointment ... as director of public safety business development. ... law enforcement experience, including a focus on the aviation ... his most recent position, Mr. Sheridan served as the ...
(Date:3/20/2017)... March 20, 2017 PMD Healthcare announces the ... and Wellness Management System (WMS), a remote, real-time lung ... 2010, PMD Healthcare is a Medical Device, Digital Health, ... dedicated to creating innovative solutions that empower people to ... intent focus, PMD developed the first ever personal spirometer, ...
(Date:3/13/2017)... Germany , March 13, 2017 Future of security: ... ... DERMALOGs Face Matching enables to match face ... forms the basis to identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for biometric ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 2017  GlobeImmune, Inc. today announced it has entered ... 12,835,490 shares of its common stock to NantCell, Inc., ... with the sale of its common stock, NantCell has ... to GlobeImmune 200,000 shares, an estimated $2.0 million in ... are pleased to enter into this strategic agreement with ...
(Date:3/23/2017)... 23, 2017 Kineta, Inc., a biotechnology ... therapies in immuno-oncology, today announced the discovery and ... compounds that activate interferon response factor 3 (IRF3) ... immune-mediated tumor regression in a murine colon carcinoma ... demonstrated complete tumor regression to initial drug treatment ...
(Date:3/23/2017)... Colo. , March 23, 2017  Agriculture technology ... Series A financing and note conversion to commercialize its ... Planet is focused on developing products that are simultaneously ... $30 million in the last 18 months. This latest ... North Bridge Venture Partners. The company,s ...
(Date:3/22/2017)... N.Y. , March 22, 2017 Regeneron Pharmaceuticals, ... the Regeneron Genetics Center (RGC), U.K. Biobank and GSK to ... the U.K. Biobank resource. The initiative will enable researchers to ... new medicines for a wide range of serious and life ... ...
Breaking Biology Technology: